PENTRAXIN-3, TROPONIN T, N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN SEPTIC PATIENTS

被引:5
|
作者
Vassalli, Francesco [1 ]
Masson, Serge [2 ,6 ]
Meessen, Jennifer [2 ]
Pasticci, Iacopo [1 ]
Bonifazi, Matteo [1 ]
Vivona, Luigi [3 ]
Caironi, Pietro [4 ,5 ]
Busana, Mattia [1 ]
Giosa, Lorenzo [1 ]
Macri, Matteo Maria [1 ]
Romitti, Federica [1 ]
Novelli, Deborah [2 ]
Quintel, Michael [1 ]
Latini, Roberto [2 ]
Gattinoni, Luciano [1 ]
机构
[1] Univ Gottingen, Dept Anaesthesiol Emergency & Intens Care Med, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, MI, Italy
[4] Azienda Osped Univ S Luigi Gonzaga, Dept Anesthesia & Crit Care, Orbassano, TO, Italy
[5] Univ Turin, Dept Oncol, Turin, Italy
[6] Roche Diagnost Int, Rotkreuz, Switzerland
来源
SHOCK | 2020年 / 54卷 / 05期
关键词
Hypoxia; lactic acid; pro-brain natriuretic peptide (1-76); pTX3; protein; troponin T; SEVERE SEPSIS; MYOCARDIAL-INFARCTION; LONG PENTRAXIN; SHOCK; MARKER; PTX3;
D O I
10.1097/SHK.0000000000001543
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To investigate the behavior of pentraxin-3 (PTX3), troponin T (hsTnT), N-terminal pro-B type Natriuretic Peptide (NT-proBNP) in sepsis and their relationships with sepsis severity and oxygen transport/utilization impairment. Design: Retrospective analysis of PTX3, hsTnT, NT-proBNP levels at day 1, 2, and 7 after admission in the intensive care unit in a subset of the Albumin Italian Outcome Sepsis database. Setting: Forty Italian intensive care units. Patients: Nine hundred fifty-eight septic patients enrolled in the randomized clinical trial comparing albumin replacement plus crystalloids and crystalloids alone. Interventions: The patientswere divided into sextiles of lactate (marker of severity), ScvO(2) (marker of oxygen transport), and fluid balance (marker of therapeutic strategy). Measurements and Main Results: PTX3 and hsTnT were remarkably similar in the two treatment arms, while NT-proBNP was almost double in the albumin treatment group. However, as the distribution of all these biomarkers was similar between control and treatment arms, for the sake of clarity, we analyzed the patients as a single cohort. PTX3 (71.8 [32.9-186.3] ng/mL), hsTnT (50.4 [21.6-133.6] ng/L), and NT-proBNP (4,393 [1,313-13,837] ng/L) were abnormally elevated in 100%, 84.5%, 93.4% of the 953 patients and all decreased from day 1 to day 7. PTX3 monotonically increased with increasing lactate levels. The hsTnT levels were significantly higher when ScvO(2) levels were abnormally low (< 70%), suggesting impaired oxygen transport compared with higher ScvO(2) levels, suggesting impaired oxygen utilization. NT-proBNP was higher with higher lactate and fluid balance. At ScvO(2) levels < 70%, the NT-proBNP was higher than at higher ScvO(2) levels. However, even with higher ScvO(2), the NT-proBNP was remarkably elevated, suggesting volume expansion. Increased level of NT-proBNP showed the strongest association with 90-day mortality. Conclusions: The selected biomarkers seem related to different mechanisms during sepsis: PTX3 to sepsis severity, hsTnT to impaired oxygen transport, NT-proBNP to sepsis severity, oxygen transport, and aggressive fluid strategy.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 50 条
  • [1] Can N-terminal pro-B-type natriuretic peptide and troponin T predict ICU and hospital mortality in patients with septic shock?
    A Turley
    M de Belder
    M Johnson
    J Gedney
    Critical Care, 10 (Suppl 1):
  • [2] N-terminal pro-B-type natriuretic peptide for predicting fluid challenge in patients with septic shock
    Huang, Hui-Bin
    Xu, Biao
    Liu, Guang-Yun
    Du, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (12)
  • [3] N-terminal pro-B-type natriuretic peptide and cardiac troponin T in non-immune hydrops
    Lee, Seung Mi
    Jun, Jong Kwan
    Kim, Su Ah
    Kang, Min Ji
    Song, Sang Hoon
    Lee, JoonHo
    Park, Chan-Wook
    Park, Joong Shin
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (04) : 380 - 384
  • [4] N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
    Ducros, Jacques
    Larifla, Laurent
    Merault, Henri
    Galantine, Valerie
    Bassien-Capsa, Valerie
    Foucan, Lydia
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2020, 2020
  • [5] High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in patients with hypertrophic cardiomyopathy
    Klopotowski, M. Mariusz
    Kukula, K.
    Dabrowski, M.
    Kwapiszewska, A.
    Jamiolkowski, J.
    Spiewak, M.
    Chmielak, Z.
    Witkowski, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 99 - 99
  • [6] N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
    Ezekowitz, Justin A.
    O'Connor, Christopher M.
    Troughton, Richard W.
    Alemayehu, Wendimagegn G.
    Westerhout, Cynthia M.
    Voors, Adriaan A.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Emdin, Michele
    Patel, Mahesh J.
    Pieske, Burkert
    Roessig, Lothar
    Hernandez, Adrian F.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2020, 8 (11) : 931 - 939
  • [7] N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD
    Sasaki, Takaya
    Oishi, Emi
    Nagata, Takuya
    Sakata, Satoko
    Chen, Sanmei
    Furuta, Yoshihiko
    Honda, Takanori
    Yoshida, Daigo
    Hata, Jun
    Tsuboi, Nobuo
    Kitazono, Takanari
    Yokoo, Takashi
    Ninomiya, Toshiharu
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 976 - 985
  • [8] Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide, and Incidence of Stroke The Atherosclerosis Risk in Communities Study
    Folsom, Aaron R.
    Nambi, Vijay
    Bell, Elizabeth J.
    Oluleye, Oludamilola W.
    Gottesman, Rebecca F.
    Lutsey, Pamela L.
    Huxley, Rachel R.
    Ballantyne, Christie M.
    STROKE, 2013, 44 (04) : 961 - +
  • [9] High sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in healthy Canadian children
    Velikovic, K.
    Kavsak, P.
    Clark, L.
    Mansour, M.
    Colantonio, D.
    Adeli, K.
    Grey, V.
    CLINICAL BIOCHEMISTRY, 2012, 45 (13-14) : 1121 - 1122
  • [10] N-Terminal Pro-B-Type Natriuretic Peptide Variability in Stable Dialysis Patients
    Fahim, Magid A.
    Hayen, Andrew
    Horvath, Andrea R.
    Dimeski, Goce
    Coburn, Amanda
    Johnson, David W.
    Hawley, Carmel M.
    Campbell, Scott B.
    Craig, Jonathan C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (04): : 620 - 629